00:00 Alexis Christopherus

We are, we’re changing it up.

00:01 Tom Gunn

Changing it up, really.

00:02 Alexis Christopherus

You’re going to like that. Kicking off the 9 o’clock hour with some stocks to watch. Why not? So, Accenture, uh ticker symbol here, A C N. that stock on the move upward today, up about 4%. Anthropic says it has partnered with Accenture, which is a technology consulting company, to test the safety of its advanced artificial intelligence models. The uh Anthropic calling this partnership an important step toward its commitment to pace development of the technology. We know there’s been so much talk about the heads of these AI companies saying that things may indeed be moving too quickly. Um, and Accenture’s shares are down more than 30% so far this year, uh uh over concerns about corporate IT spending, concerns that AI tools could take away business from professional service firms like its own. So this is a big deal uh for Accenture today.

00:48 Tom Gunn

Uh, what else we got?

00:50 Alexis Christopherus

Arhaus. Do you know this? This is the furniture store.

00:53 Tom Gunn

No.

00:53 Alexis Christopherus

Yeah, they they have a few big locations, especially one down in uh in Soho.

00:55 Tom Gunn

Really?

00:59 Alexis Christopherus

So this uh ticker symbol is ARHS, stock up more than 9%. Uh an analyst says it is likely to break back into the green as it ramps up its digital marketing and other efforts to expand its customer base. This is according to Jeffries. So the investment bank upgrading the home furnishing stock to buy from hold, raising its price target on shares to $10 from 950. Shares of Arhaus are down 31% year to date uh over by the way. And Jeffries’s call goes against the consensus on the street right now. Of the 15 analysts covering Arhaus, seven have a buy or strong buy on the stock while eight have a hold on it. But they say that over the past few weeks, they’re seeing more website traffic. It’s more than doubled on a year-over-year basis and they say they also want to expand into B2B strategy. So, business to business for Arhaus. We’ll see how that goes.

01:45 Tom Gunn

Arhaus.

01:46 Alexis Christopherus

Yeah. You know what?

01:47 Tom Gunn

No. No. All right, I learned something new today.

01:50 Alexis Christopherus

Learned something new today. Yeah. Exactly. Changing it up with Tom Gunn.

01:52 Tom Gunn

Uh, exactly. All right, one more.

01:54 Alexis Christopherus

All right. Novo Nordisk, uh disappointing investors here. They were hoping for more concrete turnaround plans from the drugmaker. We know that it was first to market with these GLP-1 weight loss drugs, but it quickly lost its lead to Eli Lily. So Novo is promising to launch more than five blockbuster drugs and deliver more than $23 billion in new sales in the coming year, but that wasn’t enough for investors. They are selling the stock today because they are not seeing concrete news that they say will drive the stock higher. Novo has fallen behind Lily despite being first to market.

02:24 Tom Gunn

All right, very good. Uh Alexis Christopherus, Stock Movers. It’s a podcast as they say, and we bring it to you every day. It’s a highlight of the day for sure.